Two teams of researchers from the Yorkshire and Humber region have been awarded £50, 000 to help them develop their innovative regenerative medicine projects; reducing the risk of infection and improving cartilage and bone implants.
One team awarded the regional regeNer8 technology validation grant is made up of scientists from the University of Leeds, University of Bradford and tissue repair specialists Neotherix Ltd. They have combined three technologies to provide an innovative approach to regenerative medicine.
Regenerative medicine aims to replace or repair diseased or damaged body parts. It is a highly multidisciplinary area including aspects of engineering, cell biology and materials science as well as covering stem cell therapy, tissue engineering, and regenerative drugs and devices.
Dr Yang, the team’s leader, said: “I am delighted to receive this funding from regeNer8 and for our work to be recognised in this way. This grant is fundamental in our ability to carry out product development and bring it to market.”
The second grant was awarded to Dr Paul Genever from the University of York for his team’s work on a cartilage and bone implant which can be customised to suit the patient’s individual needs.
The regeNer8 funding is aimed to support early stage applied research and development projects. Supported by Yorkshire Forward – the regeneration agency of Yorkshire and Humber- it aims to support growth in the healthcare sector and promote development in the North of England.
Roland Jurke, Chair of the steering group for regeNer8, said: “Congratulations to the recipients of regeNer8’s latest funding grants. These scientists are leaders in regenerative medicine and their research is paving the way for future solutions to meet medical needs. Their work is providing real value to patients and healthcare providers.”